In this regard, ALDH+/CD133+ cells in colon cancer and EpCAM+/CD133+ CSCs from hepatocellular cancer demonstrate increased activation of IL-6/STAT3 activity and causal association in CSCs niche expansion [57–59]. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.